Oklo is developing its Aurora powerhouse, a next-generation small modular reactor based on metal-fueled fast-reactor technology derived from the Experimental Breeder Reactor-II. Designed to operate for more than 10 years between refueling cycles, Aurora reactors can run on recycled nuclear fuel, potentially reducing waste and maximizing resource utilization. This technology positions Oklo to deliver a compact, factory-built nuclear plant capable of producing up to 20 megawatts of carbon-free power for industrial sites and data centers with limited grid connectivity.

In 2025, Oklo achieved a key regulatory advance by securing initial safety approvals from the U.S. Nuclear Regulatory Commission for its Aurora design. The company has completed multiple pre-application reviews and submitted its construction permit application, marking it as one of only two U.S. firms with an NRC-approved SMR design in active licensing. Oklo’s ongoing partnership with the Department of Energy’s Gateway for Accelerated Innovation in Nuclear program provides both technical guidance and cost-share funding to accelerate reactor demonstration.

Despite having no commercial reactors in operation, Oklo’s share price has surged 252% year-to-date, reflecting investor enthusiasm for advanced nuclear solutions in the AI-driven data center boom. The company’s market capitalization stands at approximately $11 billion, driven by speculative bids on its long-term revenue potential. However, the lack of binding customer contracts and the extended timeline to first revenue generation have resulted in significant stock volatility throughout 2025.

Oklo projects its first commercial Aurora reactor will enter service in 2027 or 2028, with deployment targets focused on remote industrial facilities and hyperscale data centers facing grid interconnection delays. To prepare for market entry, the company is scaling up manufacturing capacity at its Idaho facility and forging strategic partnerships with engineering firms to support site construction. Analysts caution that any delay in NRC licensing or supply-chain bottlenecks for specialized reactor components could push back commercial operations and revenue recognition beyond the current estimates.